Cargando…

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Public health measures have successfully identified and contained outbreaks of the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV)(1,2,3,4,5), but concerns remain over the possibility of future recurrences. Finding a vaccine for this virus therefore remains a high priority. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhi-yong, Kong, Wing-pui, Huang, Yue, Roberts, Anjeanette, Murphy, Brian R., Subbarao, Kanta, Nabel, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095382/ https://www.ncbi.nlm.nih.gov/pubmed/15024391 http://dx.doi.org/10.1038/nature02463

Ejemplares similares

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Animal Models for Sars
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
por: Roberts, Anjeanette, et al.
Publicado: (2007)

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
por: Roberts, Anjeanette, et al.
Publicado: (2006)

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
por: Traggiai, Elisabetta, et al.
Publicado: (2004)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice
por: Rao, Srinivas, et al.
Publicado: (2008)

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice
por: Rao, Srinivas, et al.
Publicado: (2008)

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice
por: Rao, Srinivas, et al.
Publicado: (2008)

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
por: Darnell, Miriam E.R., et al.
Publicado: (2004)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection
por: Akahata, Wataru, et al.
Publicado: (2010)

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts
por: Sheets, Rebecca L., et al.
Publicado: (2006)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023)

A multiclade DNA/Ad vaccines for AIDS: the present and next generation
por: Nabel, Gary J
Publicado: (2006)

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
por: Woo, Patrick C.Y., et al.
Publicado: (2005)

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
por: Pymm, Phillip, et al.
Publicado: (2021)

Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus
por: Tripet, Brian, et al.
Publicado: (2006)

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
por: Epstein, Suzanne L., et al.
Publicado: (2002)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
por: Baz, Mariana, et al.
Publicado: (2022)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
por: Qiu, Maofeng, et al.
Publicado: (2005)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2006)

Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells
por: Cheng, Cheng, et al.
Publicado: (2007)

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
por: Martin, Julie E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_aldlsqpahvskdog659oodin1ng